Evaluating the expression of HMGCR in HER2 negative and HER2 positive breast cancer
3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) is the rate-limiting enzyme in cholesterol biosynthesis pathway that has been associated with cancer development. Although the connection between HMGCR and HER2 has been established, the function of HMGCR in the advanced progression of HER2 pos...
Saved in:
Main Author: | Drahman, Rosmaizan |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | http://eprints.usm.my/57613/1/ROSMAIZAN%20BINTI%20DRAHMAN-FINAL%20THESIS%20P-UM000418%28R%29-24%20pages.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of HER4 isoforms and HER4 localisation in HER2 negative breast cancer cell lines
by: Ali, Nursyazana Aqilah
Published: (2021) -
Investigating the effect of andrographolide on HMGCR protein expression in MDA-MB-231
by: Abdulateef, Al-Hakam Ahmed
Published: (2019) -
BCL-2, HER1, HER2, HER3 and HER4 expression in primary colorectal adenocarcinoma
by: Ahmad Zubir, Nurul Mahirah
Published: (2017) -
The outcome of breast cancer based on
the expression of c-erbb2 , estrogen
receptor and progesterone receptor:
kelantan experience 2002-2004
by: Mohamed, Moharzudi
Published: (2010) -
Targeted delivery of vitamin E TPGS based nanomedicine for treatment of triple negative breast cancer
by: Rajaletchumy, Veloo Kutty
Published: (2015)